Double Helix Bio-technology Development Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 51
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Double Helix Bio-technology Development General Information

Description

Provider of market research and consulting services to the healthcare industry. The company offers market research, data analytic, market advisory, planning and consulting, strategy management and pharmaceutical market information services to the healthcare organizations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Other Commercial Services
Acquirer
McCann Health
Primary Office
  • 88 Baker Street
  • London W1U 6TQ
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Double Helix Bio-technology Development Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Double Helix Bio-technology Development‘s full profile, request access.

Request a free trial

Double Helix Bio-technology Development Executive Team (3)

Name Title Board Seat Contact Info
Charlie Buckwell Chief Executive Officer
Jim Goldenberg President
To view Double Helix Bio-technology Development’s complete executive team members history, request access »

Double Helix Bio-technology Development Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial